NIH-funded research Sbir 2 grant

Advanced Technology to Understand Immune Cell Behavior

Official title: Dynamic single-cell analysis instrument to evaluate immune cell function

Funded at Cellchorus INC. · NIH-11136848 · Data updated 2026-11-12

This project is creating a new technology that uses advanced imaging and artificial intelligence to better understand how individual immune cells work and interact, which can help develop new treatments.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionCellchorus INC.
NIH-funded
Lab location1 site (Houston, UNITED STATES)
Project startMay 1, 2023
Project endJuly 31, 2026
Funding year2025
Award (this year)$462,781
NIH project number5R44GM149106-03
Project IDNIH-11136848 on NIH RePORTER

Who could benefit from this research

Could help

Patients who might benefit from advanced cell therapies, such as those for cancer or autoimmune diseases, could indirectly benefit from this research.

Less likely to help

Patients not seeking or eligible for cell-based therapies would not directly benefit from this specific instrument development.

What this research studies

We are developing a new instrument called CellChorus® that uses a special imaging technique called Time-lapse Imaging Microscopy in Nanowell Grids (TIMING™) combined with artificial intelligence. This technology allows us to watch and analyze thousands of individual cells over time, including disease cells and immune cells, without destroying them. By tracking their movements, interactions, and overall performance, we can gain a much deeper understanding of how these 'living drugs' behave. This detailed insight is crucial for creating more effective cell-based therapies and identifying important signs of disease or treatment success.

Why it matters

Potential benefit: If successful, this technology could lead to the development of more effective cell therapies and better ways to predict how patients will respond to treatments.

How similar studies have gone: The CellChorus platform has already been technically and commercially validated, suggesting a strong foundation for this advanced development.

Where this research is happening

  • Cellchorus INC.
    Houston, United States
    Active

Researchers

  • Principal investigator: Cooper, Laurence J.n. — Cellchorus INC.
  • Study coordinator: Cooper, Laurence J.n.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.